This study from the International Journal of Oncology shows how the
homeopathic remedy Ruta 6 used in conjunction with CalPhos 3x was useful in
the regression of tumors in glioma patients. After getting permission from
as oncologist in Boston, I am working with a patient who was given only 2
weeks to 2 months to live, and is now making a remarkable recovery using
this protocol. His doctor has also allowed the use of antioxidants which was
originally contraindicated, as well as foods high in antioxidants. I advised
him to discontinue the supplements 24 hours before and continue the
supplements 48 hours after chemotherapy. Before using alternative methods,
his tumor was still growing while getting chemotherapy and radiation. His
speech, motor skills, and energy level have all improved.

http://147.52.72.117/IJO/2003/volume23/number4/975.pdf

Ruta 6 selectively induces cell death in brain cancer cells but
proliferation in normal peripheral blood lymphocytes: A novel treatment for
human brain cancer

Sen Pathak, Asha S. Multani, Pratip Banerji and Prasanta Banerji

Departments of 1Cancer Biology [S.P., A.S.M.] and 2Laboratory Medicine
[S.P.], The University of Texas M.D. Anderson Cancer Center, Houston, TX
77030, USA; 3PBH Research Foundation, 10/3/1 Elgin Road, Kolkata 700 020,
West Bengal, India [Pratip B, Prasanta B].
Correspondence to: Professor S. Pathak, Department of Molecular Genetics,
Box 011, M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX
77030, USA E-mail: pathak_sen@yahoo.com. Received April 16, 2003; Accepted
May 28, 2003.

Although conventional chemotherapies are used to treat patients with
malignancies, damage to normal cells is problematic.
Blood-forming bone marrow cells are the most adversely affected.
It is therefore necessary to find alternative agents that can kill cancer
cells but have minimal effects on normal cells.
We investigated the brain cancer cell-killing activity of a homeopathic
medicine, Ruta, isolated from a plant, Ruta graveolens.
We treated human brain cancer and HL-60 leukemia cells, normal B-lymphoid
cells, and murine melanoma cells in vitro with different concentrations of
Ruta in combination with Ca3(PO4)2.
Fifteen patients diagnosed with intracranial tumors were treated with Ruta 6
and Ca3(PO4)2.
Of these 15 patients, 6 of the 7 glioma patients showed complete regression
of tumors.
Normal human blood lymphocytes, B-lymphoid cells, and brain cancer cells
treated with Ruta in vitro were examined for telomere dynamics, mitotic
catastrophe, and apoptosis to understand the possible mechanism of
cell-killing, using conventional and molecular cytogenetic techniques.
Both in vivo and in vitro results showed induction of survival-signaling
pathways in normal lymphocytes and induction of death-signaling pathways in
brain cancer cells.
Cancer cell death was initiated by telomere erosion and completed through
mitotic catastrophe events.
We propose that Ruta in combination with Ca3(PO4)2 could be used for
effective treatment of brain cancers, particularly glioma.